Besides, a recent meta-analysis6 of large observational studies reported insignificant risk of AKI among different COX-2 inhibitor users, whereas in which most trials took place in more remote time periods, had small number of cases, and lacked the data from Asian ethnicity. This evidence concerns the gene PTGS2 and acute kidney injury.